The Functional Role of Long Non-Coding RNAs in Melanoma

Michal Wozniak1, Malgorzata Czyz1

  • 1Department of Molecular Biology of Cancer, Medical University of Lodz, 92-215 Lodz, Poland.

Cancers
|October 13, 2021
PubMed

Insights

Long noncoding RNAs (lncRNAs) are increasingly linked to melanoma development and treatment resistance. Understanding lncRNA roles is crucial for improving melanoma therapies and patient outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Melanoma incidence is rising globally, posing a significant public health challenge.
  • Current melanoma treatments face limitations due to drug resistance and adverse effects.
  • Long noncoding RNAs (lncRNAs) are implicated in various cancers, including melanoma.

Purpose of the Study:

  • To review the current understanding of lncRNAs in melanoma development and progression.
  • To explore the role of lncRNAs in melanoma treatment response and resistance.
  • To highlight the potential of lncRNAs as diagnostic and prognostic markers.

Main Methods:

  • Literature review of studies investigating lncRNAs in melanoma.
  • Analysis of lncRNA mechanisms in cellular processes relevant to cancer.
  • Discussion of lncRNA involvement in therapeutic resistance.

Main Results:

  • lncRNAs regulate key cellular processes such as proliferation, migration, and apoptosis.
  • Dysregulation of lncRNA expression is associated with melanoma tumorigenesis.
  • lncRNAs can influence stability, activity, and localization of molecular targets.

Conclusions:

  • lncRNAs play a significant role in melanoma pathogenesis.
  • lncRNAs show promise as biomarkers for predicting treatment response and resistance.
  • Further research into lncRNA functions is essential for advancing melanoma treatment strategies.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.3K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
12.1K
Types of RNA01:20

Types of RNA

Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
7.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K